Samsung Bioepis Gets Canadian Trastuzumab Nod
Ontruzant Biosimilar Rival To Herceptin To Be Marketed By Organon In Canada
Samsung Bioepis is celebrating approval for Ontruzant – but Canada’s biosimilar trastuzumab market is becoming crowded • Source: Rawpixel Ltd / Alamy Stock Photo 
